JUVENESCENCE
Live / Registered — Registered (as of 17 Sept 2024)
What this means for you
Registered since 17 Sept 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Sept 2030: the §8 declaration of use).
Record
- Serial number
- 88979775
- Registration number
- 7507898
- Mark type
- Word mark
- Filed
- 21 Aug 2019
- Published for opposition
- 19 Jan 2021
- Registered
- 17 Sept 2024
- Next maintenance filing
- §8 declaration of use, due by 17 Sept 2030 (grace period to 17 Mar 2031)
- Attorney of record
- Lisa W. Rosaya
Goods and services
- Class 005 — Pharmaceuticals: medicine, namely, compositions for prevention and treatment of physiological aging, cognitive aging and senescence, and for stimulation of limb and organ regeneration; pharmaceuticals, namely, compositions for prevention and treatment of physiological aging, cognitive aging and senescence, and for stimulation of limb and organ regeneration
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines for prevention and treatment of physiological aging, cognitive aging and senescence, and for stimulation of limb and organ regeneration; scientific research and development in the fields of the prevention and treatment of physiological aging, cognitive aging and senescence, and stimulation of limb and organ regeneration
Owner
- JUVENESCENCE (EUROPE) LIMITED, DUBLIN 2, IE
- JUVENESCENCE (EUROPE) LIMITED, DUBLIN 2, IE
- Juvenescence UK Limited, London, GB
- Juvenescence UK Limited, London, GB
Board proceedings on this mark
- Extension of Time to Oppose No. 88979775 — Allergan Holdings France SAS v. Juvenescence UK Limited, filed 16 Feb 2021 (Terminated)
Prosecution history
- 17 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2024 — ASSIGNED TO LIE
- 27 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Dec 2023 — NON-FINAL ACTION E-MAILED
- 11 Dec 2023 — SU - NON-FINAL ACTION - WRITTEN
- 12 Sept 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Sept 2023 — USE AMENDMENT FILED
- 06 Sept 2023 — TEAS STATEMENT OF USE RECEIVED
- 04 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED